Your browser doesn't support javascript.
loading
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
Bosi, Carlo; Bartha, Áron; Galbardi, Barbara; Notini, Giulia; Naldini, Matteo M; Licata, Luca; Viale, Giulia; Mariani, Marco; Pistilli, Barbara; Ali, H Raza; André, Fabrice; Piras, Marta; Callari, Maurizio; Barreca, Marco; Locatelli, Alberta; Viganò, Lucia; Criscitiello, Carmen; Pusztai, Lajos; Curigliano, Giuseppe; Gyorffy, Balázs; Dugo, Matteo; Bianchini, Giampaolo.
Afiliação
  • Bosi C; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Bartha Á; Department of Bioinformatics, Semmelweis University, Tuzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary.
  • Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Notini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Naldini MM; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Licata L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Mariani M; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.
  • Ali HR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
  • André F; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.
  • Piras M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Callari M; Fondazione Michelangelo, Milan, Italy.
  • Barreca M; Fondazione Michelangelo, Milan, Italy.
  • Locatelli A; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Viganò L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Criscitiello C; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
  • Pusztai L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.
  • Gyorffy B; Department of Bioinformatics, Semmelweis University, Tuzoltó Utca 7-9, 1094 Budapest, Hungary; Research Centre for Natural Sciences, Oncology Biomarker Research Group, Institute of Molecular Life Sciences, Eötvös Loránd Research Network, Magyar Tudósok Körútja 2, 1117 Budapest, Hungary.
  • Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: dugo.matteo@hsr.it.
  • Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: bianchini.giampaolo@hsr.it.
Eur J Cancer ; 195: 113379, 2023 12.
Article em En | MEDLINE | ID: mdl-37913680

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article